Structure Therapeutics Inc. - ADR
News
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $84.63 Consensus Target Price from Brokerages
Zolmax Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seven research firms that are covering the stock, MarketBeat.com reports...\n more…
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Rating of "Buy" by Analysts
Ticker Report Shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) have earned a consensus rating of "Buy" from the seven ratings firms that are covering the stock, Marketbeat Ratings reports...\n more…
Structure Therapeutics Appoints Angus Russell to Board
TipRanks Financial Blog The latest announcement is out from Structure Therapeutics, Inc. Sponsored ADR (GPCR). Structure Therapeutics Inc. enhanced its boardroom acumen by welcoming Angus ...\n more…
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
Globe Newswire Former Shire CEO brings more than 30 years of experience in building and scaling companies in the global biopharmaceutical industrySAN FRANCISCO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Structure...\n more…
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
Globe Newswire SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...\n more…
Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $39.64
Ticker Report Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report)'s share price gapped up before the market opened on Thursday . The stock had previously closed at $39.64, but opened at $41.00. Structure...\n more…